Quantum eMotion, a developer of quantum-resistant security technology, has initiated a formal process to list its shares on a major US exchange. The company has filed a registration statement with the Securities and Exchange Commission (SEC), targeting a listing on the NYSE American. This strategic move aims to broaden its investor base, though final approval hinges on regulatory and exchange decisions.
Key Developments and Financial Position
The company’s recent regulatory filing marks a pivotal step in its expansion strategy. Below are the core details investors should note:
* Regulatory Filing: A Form 40‑F Registration Statement was submitted to the SEC in January.
* Listing Target: The application seeks to list the company’s common shares on the NYSE American.
* Approval Process: A successful listing remains contingent upon the SEC declaring the registration effective and the NYSE American granting final approval, confirming all listing standards are met.
* Financial Standing: As of its last reported quarter, Q3 2025, Quantum eMotion held a cash position of 24.71 million CAD.
The firm has committed to providing further updates as the listing process advances.
Strategic Initiatives and Recent Partnerships
Beyond the US listing ambitions, Quantum eMotion has been active on several strategic fronts in recent months. The company entered a strategic alliance with Jmem Technology in September 2025, focused on creating quantum-resilient system-on-chip technology.
Should investors sell immediately? Or is it worth buying Quantum eMotion?
Subsequent months saw further activity:
* November: A partnership commenced with Exascale Labs to collaborate on quantum-secured artificial intelligence computing infrastructure.
* December: The company joined the Kirq quantum communications testbed in Quebec.
* December: Corporate communications indicated the stock represented a significant holding within the Defiance Quantum ETF.
Implications of a Dual Listing
Currently, Quantum eMotion’s equity trades on the TSX Venture Exchange in Canada. Securing a secondary listing on the NYSE American is viewed as a pathway to enhanced visibility and accessibility for a larger pool of U.S.-based institutional and retail investors. The ultimate impact, however, is directly tied to the timing and successful completion of the regulatory review.
Market observers are now focused on two sequential milestones: the SEC’s declaration of effectiveness for the Form 40‑F filing, followed by the final listing decision from the NYSE American. The company has stated it will inform the market promptly when new material details regarding the listing progress become available.
Ad
Quantum eMotion Stock: Buy or Sell?! New Quantum eMotion Analysis from February 7 delivers the answer:
The latest Quantum eMotion figures speak for themselves: Urgent action needed for Quantum eMotion investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.
Quantum eMotion: Buy or sell? Read more here...
